Literature DB >> 2821817

Epstein-Barr viral DNA in tissues of Hodgkin's disease.

L M Weiss1, J G Strickler, R A Warnke, D T Purtilo, J Sklar.   

Abstract

Tissue specimens from 21 cases of Hodgkin's disease were examined for the presence of Epstein-Barr virus (EBV) and cytomegalovirus DNA by molecular hybridization techniques. EBV DNA was detected in 4 cases, including 2 of 8 cases which had been previously shown to contain clonal immunoglobulin gene rearrangements. Two of the cases containing EBV DNA were of the nodular sclerosing type and had received prior therapy; the other 2 were classified as mixed cellularity Hodgkin's disease and had not received therapy before the biopsy tissue was obtained. Analyses of the terminal portions of EBV genomes indicated a monoclonal or oligoclonal proliferation of EBV-infected cells in the tissues studied. In contrast, none of the 21 cases had detectable cytomegalovirus DNA sequences. The identification of EBV DNA may reflect the proliferation of lymphoblastoid cells due to the reduced immune competence frequently noted in Hodgkin's disease or may indicate the presence of EBV genomes within Reed-Sternberg cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821817      PMCID: PMC1899692     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Epstein-Barr virus DNA in human lymphoid cell lines: in vitro conversion.

Authors:  M Andersson; T Lindahl
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

3.  Epidemiology of hodgkin's disease in the young.

Authors:  N Gutensohn; P Cole
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

4.  Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.

Authors:  T Lindahl; G Klein; B M Reedman; B Johansson; S Singh
Journal:  Int J Cancer       Date:  1974-06-15       Impact factor: 7.396

5.  Amount of viral DNA in the genome of cells transformed by adenovirus type 2.

Authors:  U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1973-01       Impact factor: 5.469

6.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Authors:  J D Fingeroth; J J Weis; T F Tedder; J L Strominger; P A Biro; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure.

Authors:  F C Kafatos; C W Jones; A Efstratiadis
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

8.  Organization of repeated regions within the Epstein-Barr virus DNA molecule.

Authors:  S D Hayward; L Nogee; G S Hayward
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

9.  Epstein--Barr virus-induced cell fusion.

Authors:  G J Bayliss; H Wolf
Journal:  Nature       Date:  1980-09-11       Impact factor: 49.962

10.  Infectious mononucleosis and Hodgkin's disease.

Authors:  N Muñoz; R J Davidson; B Witthoff; J E Ericsson; G De-Thé
Journal:  Int J Cancer       Date:  1978-07-15       Impact factor: 7.396

View more
  85 in total

Review 1.  Gammaherpesviruses and "Hit-and-Run" oncogenesis.

Authors:  R F Ambinder
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Hodgkin's disease and the Epstein-Barr virus.

Authors:  K J Flavell; P G Murray
Journal:  Mol Pathol       Date:  2000-10

3.  Detection of Epstein-Barr virus genome in Ki-1 (CD30)-positive, large-cell anaplastic lymphomas using the polymerase chain reaction.

Authors:  C W Ross; J A Schlegelmilch; T M Grogan; L M Weiss; B Schnitzer; C A Hanson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

4.  Epstein-Barr virus and Hodgkin's disease.

Authors:  M M Reid
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

Review 5.  In situ hybridisation in perspective.

Authors:  A Warford; I Lauder
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

6.  Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.

Authors:  Amy L Ellis; Zhenxun Wang; Xianming Yu; Janet E Mertz
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

Review 7.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

9.  Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study.

Authors:  L M Weiss; Y Y Chen; X F Liu; D Shibata
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

10.  De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

Authors:  A Matolcsy; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.